On June 13, Gelonhui reported that according to the business positioning and development plan of Yixintang Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company"), Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanxi Yixintang"), a wholly-owned subsidiary of the company, intends to acquire the assets and inventory of 15 pharmacies held by Yangquan Baiji Pharmacy Co., Ltd. (hereinafter referred to as "Yangquan Baiji Pharmacy") for no more than 20.2 million yuan, of which no more than 17.5 million yuan will be used to pay for store transfer fees and purchase its affiliated assets (excluding inventory), and no more than 2.7 million yuan will be used to purchase store inventory goods (the physical assets and inventory items will be settled according to the actual inventory of both parties). The acquisition will be paid with its own funds.
By acquiring the stores of Yangquan Baiji Pharmacy, the company will strengthen and consolidate its position in the Shanxi market, expand its coverage, and comprehensively enhance its competitiveness. It is estimated that the target stores will increase revenue by 27.1993 million yuan in the past 12 months and the net profit will increase by 1.7177 million yuan.